NORML
JANUARY 28, 2019
. % Change ( +/-) from previous year. 2 years before medical legalization, the largest number of vehicle-related fatalities in the last 17 years. 1 year prior to legalization. Sales began January 1.
Veriheal
NOVEMBER 30, 2021
Johnson’s work with psychedelics began back in 2004, according to the Johns Hopkins website. He conducted the first blinded human research study into the psychoactive effects of salvinorin A in 2011 and published data on MDMA pill testing services in 2017. In 2008, he published psychedelic safety guidelines.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
JULY 6, 2021
In 2004 Dr. Johnson was inducted into the Texas Hall of Fame for Science, Mathematics and Technology. He served on the National Advisory Council for NIH/NIDA from 2004 – 2007 and was a member of the Medications Development Subcommittee of NIDA’s Advisory Council on Drug Abuse during the same period.
Cannabis Law Report
OCTOBER 31, 2019
Data for the most recent year was downloaded on October 23, 2019. Data for the most recent year was downloaded on October 23, 2019. All lobbying expenditures in the report come from the USA Senate Office of Public Records. Here’s the lowdown. From almost zero spend across the industry in 2011 to almost $US4 Million this year. .
Cannabis Law Report
OCTOBER 12, 2021
Rick Loughrey, the company’s head of BI and IT Development, has been at Camira since 2004. Loughrey’s initial interest in Cleo centred on Camira’s need to bring their EDI (electronic data interchange) solution in-house, with a view toward taking greater control of customer on-boarding. 1.815.282.7695.
The Joint Blog
FEBRUARY 24, 2021
In a 2004 survey by the Prague Movement Disorder Centre, 25% of 339 respondents had tried a form of cannabis-based treatment. It discusses a study approved by The Colorado Multiple Institutional Review Board used to collect anonymous data from a wide range of patients. Out of these respondents, 45.9%
Healer
MAY 10, 2019
The safety profile of cannabis in pregnancy, from the little data available, is comparable to other medications in category C (suspected of causing harmful effects on the fetus that may be reversible). Data from human and nonhuman species converge on the ephemeral nature of THC-induced testosterone decline. 2004): 189-197.
Expert insights. Personalized for you.
188 
Let's personalize your content